To address this issue, we employed comprehensive transgenic mouse models with Lgr5-expressing, colon stem cell lineage-specific knock-in and knockout of YTHDF1, and demonstrated that CSC-specific YTHDF1 manipulation in mice drives CRC tumorigenesis and elicits chemotherapy resistance. The gene discussed is LGR5; the disease is colorectal carcinoma.